JS

Jean Stephenne

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

Jean Stephenne attended universite gembloux.

Investor Profile

Jean Stephenne has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (50%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Information Technology
  • Therapeutics
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jean Stephenne frequently co-invest with?

Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 1
Innovation Fund
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
N
Europe, Liege, Belgium, Eupen
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
QI
Europe, Oost-Vlaanderen, Belgium, Ghent
Co-Investments: 1

Which angels does Jean Stephenne often collaborate with?

JD
Europe, Namur, Belgium, Havelange
Shared Deals: 1
DA
Europe, Liege, Belgium, Liège
Shared Deals: 1
FB
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
RT
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Jean Stephenne?

EyeD Pharma

Liège, Liege, Belgium

EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.

BiopharmaBiotechnologyPharmaceutical
Series UnknownDec 24, 2021
Amount Raised: $50,951,260
Cognivia

Mont-saint-guibert, Brabant Wallon, Belgium

Cognivia develops analytical tools to optimize and speed the clinical development of novel medicines.

BiotechnologyHealth CareInformation TechnologyTherapeutics
Series BMay 16, 2019
Amount Raised: $4,469,279